Medical Technology Innovation Ruling Issued By This Medicaid Company
Medical Technology Innovation Ruling Issued By This Medicaid Company
CMS Codifies Medicare Coverage for Ekso Indego Personal: A Game Changer for Exoskeleton Devices.
The Centers for Medicare & Medicaid Services (CMS) recently issued a ground-breaking ruling that could significantly expand the use of exoskeleton-type devices, such as the Ekso Indego Personal, in home and community markets. This decision is being hailed as a potentially game-changing event in the field of assistive technology.
The Ekso Indego Personal, a powered exoskeleton developed by Ekso Bionics, is one of the devices that stand to benefit from this ruling. This device provides individuals with spinal cord injuries or stroke the ability to stand and walk, thus enhancing their mobility and independence.
Ekso Bionics has expressed support for the CMS's proposed rule, which would clarify the scope of the Medicare Part B benefit category by including personal exoskeletons within it. This inclusion is a significant step forward, as it opens up new avenues for Medicare payment purposes.
Medicare's coverage of innovative technology (MCIT) pathway will accelerate the coverage of new, breakthrough devices for beneficiaries. As per Title XVIII of the Social Security Act, §1862(a)(1)(A), only medically reasonable and necessary services are covered by Medicare. The CMS's ruling ensures that devices like the Ekso Indego Personal fall under this category, making them more accessible to those who need them the most.
Moreover, the CMS has also finalized its proposal to codify how it defines “reasonable and necessary” coverage for items and services under the Medicare program. This move is expected to bring more clarity and transparency in terms of what can be covered under Medicare.
This development is not just a win for Ekso Bionics but also for those who rely on assistive technology for their daily activities. It's an affirmation of the importance of innovative medical devices in enhancing the quality of life for individuals with disabilities.
In conclusion, the CMS's decision to codify Medicare coverage for exoskeleton-type devices like the Ekso Indego Personal is a significant milestone in the field of assistive technology. It paves the way for increased access to these life-changing devices, thus opening up new possibilities for people with mobility impairments.
Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.
As an investor it's important to stay updated with major news. Get real-time alerts by creating an account here.